3SBio Investor Relations Material
Latest events
H2 2024
25 Mar, 2025
H1 2024
21 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 3SBio Inc
Access all reports
3SBio Inc. is a China-based biotechnology company engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. The company focuses on therapeutic areas such as oncology, nephrology, autoimmune diseases, and dermatology. Its product portfolio includes monoclonal antibodies, recombinant proteins, and other biologic treatments. The company is headquartered in Shenyang, China, and its shares are listed on the HKEX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
1530
Country
🇭🇰 Hong Kong